BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  New funding for Lac La Ronge Wellness, Healing and Recovery Centre

  Reconfirms commitment to increasing access to mental health and wellness supports for First Nations

  February 14, 2019

   · 

  3 min read
• Pharm Country

  Provider Behavior Change and Value-Based Incentives: AJMC® Study Says More Can Be Done to Accelerate Healthcare Transformation

  Research in The American Journal of Managed Care® examines care delivery in physician organizations in California and their experience in value-based payment arrangements

  February 14, 2019

   · 

  3 min read
• Bio NC

  Adameve.com Reveals Stats On Americans’ Condom Use

  Adam & Eve and adameve.com, America’s most trusted source for adult products, is back with new results from their annual sex survey.

  February 14, 2019

   · 

  1 min read
• Business

  Ascentage Pharma Appoints Jeff Kmetz as Chief Business Officer

  Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases, announced the appointment of Jeff Kmetz as Chief Business Officer.

  February 14, 2019

   · 

  2 min read
• FDA

  Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

  Bio-Rad Laboratories, Inc. announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration clearance.

  February 14, 2019

   · 

  4 min read
• Deals

  Stealth BioTherapeutics Announces Pricing of Initial Public Offering

  Stealth BioTherapeutics announced the pricing of its initial public offering of 6,500,000 American Depositary Shares, each representing 12 ordinary shares of Stealth, at an initial public offering price of $12.00 per ADS.

  February 14, 2019

   · 

  4 min read
• Business

  Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M

  Cannabis shipments totaled 10,102 kilograms and kilogram equivalents.

  February 14, 2019

   · 

  31 min read
• Policy

  California Mesothelioma Victims Center Urges a Navy Veteran or Maritime Worker with Mesothelioma or Lung Cancer Anywhere in California To Call Them for Direct Access to Famed Attorney Erik Karst to Discuss Compensation

  The group would prefer the person with mesothelioma or asbestos exposure lung cancer in California get answers to the specific questions about financial compensation directly from attorney Erik Karst.

  February 14, 2019

   · 

  3 min read
• Biotech Beach

  International Myeloma Foundation (IMF) Launches Myeloma Action Month March 1

  The International Myeloma Foundation (IMF) is harnessing the power of myeloma patients, their families, and the myeloma community at large to raise awareness of the disease during Myeloma Action Month (MAM), starting March 1, 2019

  February 14, 2019

   · 

  4 min read
• Biotech Beach

  Tanabe Research Labs Announce FDA Acceptance of its IND Application for TR1801-ADC (MT-8633), an ADC Targeting cMet Positive Solid Tumors

  Tanabe Research Laboratories U.S.A. Inc. (TRL), a subsidiary of Mitsubishi Tanabe Pharmaceutical Corporation, is a California based research, development and clinical stage company specializing in antibody technologies to treat cancer and other diseases with unmet medical needs.

  February 14, 2019

   · 

  2 min read